Cannara Biotech Inc (LOVE.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Sales | 107,203 | 81,748 | 57,260 | 35,841 | 17,020 |
| Cost of Goods | 60,100 | 51,961 | 30,029 | 18,510 | 6,724 |
| Gross Profit | 47,103 | 29,787 | 27,231 | 17,331 | 10,297 |
| Operating Expenses | 25,329 | 21,742 | 15,210 | 12,356 | 9,997 |
| Operating Income | 21,773 | 8,045 | 12,021 | 4,976 | 299 |
| Interest Expense | 3,765 | 4,847 | 4,531 | 2,789 | 1,709 |
| Other Income | 88 | 1,286 | -544 | 119 | -118 |
| Pre-tax Income | 18,097 | 4,484 | 6,945 | 2,305 | -1,528 |
| Income Tax | 5,021 | -1,955 | N/A | N/A | N/A |
| Net Income Continuous | 13,076 | 6,438 | 6,945 | 2,305 | -1,528 |
| Net Income | $13,076 | $6,438 | $6,945 | $2,305 | $-1,528 |
| EPS Basic Total Ops | 0.14 | 0.07 | 0.08 | 0.10 | -0.10 |
| EPS Basic Continuous Ops | 0.14 | 0.07 | 0.08 | 0.10 | -0.10 |
| EPS Diluted Total Ops | 0.14 | 0.07 | 0.08 | 0.10 | -0.10 |
| EPS Diluted Continuous Ops | 0.14 | 0.07 | 0.08 | 0.10 | -0.10 |
| EBITDA(a) | $28,547 | $15,683 | $16,419 | $9,015 | $3,208 |